<DOC>
	<DOCNO>NCT00709553</DOCNO>
	<brief_summary>The purpose study assess effect multiple oral dos ZD4054 ( Zibotentan ) pharmacokinetics CYP450 3A Probe ( midazolam ) healthy male subject .</brief_summary>
	<brief_title>Drug Interaction Study Asses Multiple Doses ZD4054 ( Zibotentan )</brief_title>
	<detailed_description />
	<mesh_term>Midazolam</mesh_term>
	<criteria>BMI 18 30 kg/m2 Medical surgical history physical examination without clinically significant finding Normal rest ECG QTcB interval &lt; 450ms Definite suspect personal history family history hypersensitivity drug endothelin antagonist ; ie , ambrisentan , artrasentan , sitaxsetan bosentan Healthy volunteer know hypersensitivity midazolam excipients midazolam tablet Medical diagnosis migraine attack 12 month prior Screening</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>ZD4054</keyword>
	<keyword>Healthy Volunteers</keyword>
</DOC>